Tuberculosis
- 16 July 1959
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 261 (3) , 131-139
- https://doi.org/10.1056/nejm195907162610306
Abstract
(Concluded)ChemoprophylaxisChemoprophylaxis is experiencing wider recognition. It was discussed by the panel† on this subject at the Deborah International Symposium on Tuberculosis on November 20, 1958, in Philadelphia.65 There, it was made clear that chemoprophylaxis should properly be considered in two ways: Primary prophylaxis, or drug therapy with isoniazid before tuberculous infection has occurred. Secondary prophylaxis, or isoniazid treatment after infection has occurred.Strictly speaking, by definition, prophylaxis66 means "the preventing of disease" — from the Greek, "take precautions against" — "before" infection, or "defending or protecting from disease." Thus, so-called primary prophylaxis before infection has occurred is the . . .Keywords
This publication has 6 references indexed in Scilit:
- WHY HAVE WE NOT ACCEPTED BCG VACCINATION?JAMA, 1957
- Systemic Treatment of Primary TuberculosisNew England Journal of Medicine, 1956
- Tuberculin Hypersensitivity in Tuberculous Infants Treated with IsoniazidNew England Journal of Medicine, 1955
- APPRAISAL OF PROTECTIVE VALUE OF BCG VACCINEJAMA, 1952
- B.C.G. VaccinationBMJ, 1948
- Ten years' experience with BCG (experimental and clinical)The Journal of Pediatrics, 1945